Molecheck’s® expert skin cancer doctors are trained to international standards in dermoscopy, enabling them to diagnose melanoma and other skin cancers often before they can be detected with a standard scan.
Founder of Molecheck® Dr David Langford, has been New Zealand's Board member on the International Dermoscopy Society.
He is internationally recognised for his expertise in skin cancer and melanoma diagnosis and is a co-author of eight papers published in highly-respected British and American medical journals. His expertise in skin cancer has been acknowledged by his peers and he has been both a speaker and a chairman at international conferences on dermoscopy and skin cancer. Dr Langford has personally overseen the training of Molecheck® doctors to ensure that they have all achieved a world-class level of skill in the early diagnosis of skin cancer with dermoscopy.
Dr Langford is passionate about his subject and his enthusiasm is supported by unparalleled knowledge. He formed Molecheck® 18 years ago and has built a respected skin cancer service focused on delivering clients accurate and timely results. He believes that it is important for clients to have direct access to his team of doctors who share his passion and dedication to the diagnosis and treatment of skin cancer. So when you visit Molecheck® you will be seen by a highly-skilled skin cancer doctor who is able to make a diagnosis on the spot – you will not be checked by a technician or nurse.
What is the International Dermoscopy Society (IDS)?
The International Dermoscopy Society was formed in 2003 to promote clinical research in dermoscopy with a view to helping and improving education of doctors in dermoscopy. The board of the IDS is composed of most of the world's leading experts in dermoscopy. Dr Langford has been priviledged to be on the board of the IDS since its inception. By engaging Molecheck® to conduct your skin cancer examination you are tapping into this invaluable resource. You can be assured that Molecheck® doctors are up-to-date with global advances in the field of skin cancer diagnosis and treatment.